Venture Life shares jump 18% on €62m sale of manufacturing arm and non-core products

  • Venture Life Group shares climbed 18% in early trading on Monday after the company agreed to sell its contract manufacturing operations and certain peripheral products for €62 million in cash. The deal, with Italian firm BioDue, marks a shift in strategy for the UK-based healthcare group, which says it is moving away from capital-intensive manufacturing to focus on its higher-margin consumer brands.